Core Viewpoint - A class action lawsuit has been filed against PomDoctor Ltd. for alleged securities fraud and unlawful business practices, with a significant drop in share price following a promotional scheme [2][4]. Group 1: Lawsuit Details - The class action lawsuit is initiated by investors who believe PomDoctor and its officers engaged in securities fraud [2]. - Investors have until April 6, 2026, to request to be appointed as Lead Plaintiff if they purchased PomDoctor securities during the Class Period [2]. Group 2: Share Price Movement - PomDoctor's share price increased from $4.00 at its IPO to an all-time high of $6.09 before crashing by approximately 91% to $0.50 on December 10, 2025 [4][5]. - The price surge occurred without any fundamental news justifying the increase, leading to investigations into the company's practices [4]. Group 3: Allegations of Fraud - Investigations revealed that PomDoctor allegedly used social media for a "pump and dump" scheme, misleading investors through impersonators posing as financial advisors [4]. - The scheme involved creating a buying frenzy among retail investors with sensational but unfounded claims [4].
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM